SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-23-000127
Filing Date
2023-08-15
Accepted
2023-08-15 16:04:22
Documents
1
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1692129854.html 4  
1 FORM 4 wk-form4_1692129854.xml 4 5397
  Complete submission text file 0001439222-23-000127.txt   6811
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Smith Cynthia (Reporting) CIK: 0001609480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 231174850